Nisa Investment Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26
Closed -$421 3003
2025
Q2
$421 Sell
26
-20
-43% -$345 ﹤0.01% 2897
2025
Q1
$841 Sell
46
-12
-21% -$343 ﹤0.01% 2680
2024
Q4
$2.13K Buy
58
+20
+53% +$765 ﹤0.01% 2469
2024
Q3
$1.21K Buy
38
+1
+3% +$56 ﹤0.01% 2529
2024
Q2
$3.05K Buy
37
+2
+6% +$216 ﹤0.01% 2329
2024
Q1
$5.04K Buy
35
+5
+17% +$422 ﹤0.01% 2117
2023
Q4
$2.8K Sell
30
-63
-68% -$6.41K ﹤0.01% 2164
2023
Q3
$15.3K Buy
93
+63
+210% +$8.19K ﹤0.01% 2083
2023
Q2
$1.92K Hold
30
﹤0.01% 2371
2023
Q1
$1K Sell
30
-3,310
-99% -$173K ﹤0.01% 2359
2022
Q4
$193K Buy
3,340
+3,310
+11,033% +$204K ﹤0.01% 1378
2022
Q3
$3K Sell
30
-130
-81% -$18.5K ﹤0.01% 2336
2022
Q2
$36K Sell
160
-220
-58% -$73.7K ﹤0.01% 1848
2022
Q1
$209K Buy
380
+280
+280% +$169K ﹤0.01% 1360
2021
Q4
$67K Sell
100
-9
-8% -$6.88K ﹤0.01% 1648
2021
Q3
$91 Hold
109
﹤0.01% 1743
2021
Q2
$138 Hold
109
﹤0.01% 1553
2021
Q1
$120 Hold
109
﹤0.01% 1672
2020
Q4
$156K Buy
109
+10
+10% +$10.7K ﹤0.01% 1574
2020
Q3
$70K Buy
99
+70
+241% +$50.9K ﹤0.01% 1660
2020
Q2
$20K Buy
+29
New +$16.7K ﹤0.01% 1774

Other funds holding CDLX

Nisa Investment Advisors's CDLX Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 26 shares — an estimated $421 sold.

Nisa Investment Advisors first reported a position in CDLX in Q2 2020 and held it in 21 quarters. The position peaked at $209K in Q1 2022. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 26 Cardlytics shares in Q3 2025, an estimated $421.
  • Nisa Investment Advisors first reported a position in Cardlytics in Q2 2020 and held it in 21 quarters.
  • Nisa Investment Advisors's Cardlytics position peaked at $209K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.